See more : SuRo Capital Corp. (SSSS) Income Statement Analysis – Financial Results
Complete financial analysis of InnovAge Holding Corp. (INNV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InnovAge Holding Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Southern Missouri Bancorp, Inc. (SMBC) Income Statement Analysis – Financial Results
- Novatech Industries (MLNOV.PA) Income Statement Analysis – Financial Results
- Coventry Group Ltd (CYG.AX) Income Statement Analysis – Financial Results
- Hércules S.A – Fábrica de Talheres (HETA3.SA) Income Statement Analysis – Financial Results
- Diplomat Holdings Ltd (DIPL.TA) Income Statement Analysis – Financial Results
InnovAge Holding Corp. (INNV)
About InnovAge Holding Corp.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 763.86M | 688.09M | 698.64M | 637.80M | 567.19M | 465.63M |
| Cost of Revenue | 631.79M | 586.80M | 563.27M | 463.72M | 425.89M | 355.00M |
| Gross Profit | 132.06M | 101.29M | 135.37M | 174.08M | 141.30M | 110.63M |
| Gross Profit Ratio | 17.29% | 14.72% | 19.38% | 27.29% | 24.91% | 23.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 111.34M | 115.64M | 101.65M | 132.33M | 58.48M | 48.25M |
| Selling & Marketing | 24.96M | 19.63M | 24.20M | 22.24M | 19.00M | 16.46M |
| SG&A | 136.29M | 135.26M | 125.85M | 154.57M | 77.48M | 64.71M |
| Other Expenses | 18.95M | 124.00K | 13.92M | 30.51M | 12.21M | 6.24M |
| Operating Expenses | 155.24M | 150.68M | 139.78M | 185.07M | 89.69M | 70.95M |
| Cost & Expenses | 787.04M | 737.48M | 703.05M | 648.79M | 515.58M | 425.96M |
| Interest Income | 0.00 | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Interest Expense | 4.02M | 1.52M | 2.53M | 16.79M | 14.62M | 9.59M |
| Depreciation & Amortization | 18.95M | 20.02M | 13.92M | 12.29M | 11.29M | 9.00M |
| EBITDA | 1.15M | -29.25M | 9.21M | -5.89M | 61.54M | 45.92M |
| EBITDA Ratio | 0.15% | -4.92% | 1.32% | 1.35% | 10.85% | 10.12% |
| Operating Income | -23.18M | -49.40M | -4.71M | -3.70M | 50.93M | 39.68M |
| Operating Income Ratio | -3.03% | -7.18% | -0.67% | -0.58% | 8.98% | 8.52% |
| Total Other Income/Expenses | 1.36M | -1.40M | -2.83M | -22.63M | -15.30M | -14.29M |
| Income Before Tax | -21.82M | -50.79M | -7.24M | -34.97M | 35.63M | 25.39M |
| Income Before Tax Ratio | -2.86% | -7.38% | -1.04% | -5.48% | 6.28% | 5.45% |
| Income Tax Expense | 1.40M | -7.24M | 723.00K | 9.77M | 9.87M | 6.32M |
| Net Income | -21.34M | -40.67M | -7.96M | -44.74M | 26.28M | 19.58M |
| Net Income Ratio | -2.79% | -5.91% | -1.14% | -7.01% | 4.63% | 4.20% |
| EPS | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| EPS Diluted | -0.16 | -0.30 | -0.06 | -0.33 | 0.20 | 0.15 |
| Weighted Avg Shares Out | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
| Weighted Avg Shares Out (Dil) | 135.90M | 135.59M | 135.52M | 135.52M | 133.19M | 133.19M |
3 Medical Services Stocks to Buy Amid Industry Challenges
InnovAge Holding Corp. (INNV) Q2 2023 Earnings Call Transcript
InnovAge Holding Corp. (INNV) Reports Q2 Loss, Lags Revenue Estimates
InnovAge to Announce Fiscal Second Quarter 2023 Financial Results and Host Conference Call Tuesday, February 7, 2023
InnovAge Holding: Wait For Audit Overhang To Pass Before Investing
InnovAge Holding Corp. (INNV) Q1 2023 Earnings Call Transcript
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates
InnovAge to Announce Fiscal First Quarter 2023 Financial Results and Host Conference Call Tuesday, November 8, 2022
4 Toxic Stocks That May Risk Your Peace and Prosperity
InnovAge Holding Corp. (INNV) Q4 2022 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports